ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| WntResearch AB | WNT | Sweden | — | 522 |
| CanBas Co.,Ltd. | 4575 | Japan | — | 521 |
| CLARITY PHARMACEUTICALS LTD | CU6 | Australia | — | 520 |
| Spring Bank Pharmaceuticals Inc Delisted | SBPH | United States of America | — | 520 |
| MAP Pharmaceuticals, Inc. Delisted | — | United States of America | — | 518 |
| Tricida, Inc. Delisted | — | United States of America | — | 518 |
| Zynerba Pharmaceuticals Inc Delisted | ZYNE | United States of America | — | 518 |
| Anadys Pharmaceuticals Inc Delisted | ANDS | United States of America | — | 516 |
| Cellid Co., Ltd. | 299660 | South Korea | — | 514 |
| NYRADA INC. | NYR | Australia | — | 514 |
| Curagen Corp Delisted | CRGN | United States of America | — | 511 |
| OncoMed Pharmaceuticals Inc Delisted | OMED | United States of America | — | 511 |
| KAINOS MEDICINE, INC. | 284620 | South Korea | — | 509 |
| Neovacs | ALNEV | France | — | 508 |
| NovMetaPharma Co., Ltd. | 229500 | South Korea | — | 507 |
| Zosano Pharma Corp Delisted | ZSAN | United States of America | — | 506 |
| RADIOPHARM THERANOSTICS LIMITED | RAD | Australia | — | 504 |
| Unity Biotechnology Inc Delisted | UBX | United States of America | — | 504 |
| Peptron, Inc. | 087010 | South Korea | — | 503 |
| MEMORY PHARMACEUTICALS CORP Delisted | — | United States of America | — | 502 |
| INVENTISBIO CO., LIMITED. | 688382 | China | — | 497 |
| ABL Bio Inc. | 298380 | South Korea | — | 493 |
| ATHEROGENICS INC Delisted | AGIXQ | United States of America | — | 493 |
| ZYMOGENETICS INC Delisted | — | United States of America | — | 493 |
| Dermira, Inc. Delisted | — | United States of America | — | 490 |
| MyoKardia Inc Delisted | MYOK | United States of America | — | 490 |
| Vaneltix Pharma, Inc. Delisted | — | United States of America | — | 489 |
| NEUROLOGIX INC Delisted | — | United States of America | — | 487 |
| Ocera Therapeutics, Inc. Delisted | — | United States of America | — | 487 |
| NovAccess Global Inc. Delisted | — | United States of America | — | 483 |
| Zymeworks BC Inc. Delisted | — | United States of America | — | 483 |
| Pharmadrug Inc. | PHRX | Canada | — | 481 |
| Karuna Therapeutics Inc Delisted | KRTX | United States of America | — | 478 |
| Kindred Biosciences Inc Delisted | KIN | United States of America | — | 478 |
| Morphic Holding Inc Delisted | MORF | United States of America | — | 475 |
| Arch Biopartners Inc. | ARCH | Canada | — | 472 |
| Genor Biopharma Holdings Limited | 6998 | Cayman Islands | — | 471 |
| TAMIR BIOTECHNOLOGY, INC. Delisted | — | United States of America | — | 470 |
| Abbisko Cayman Limited | 2256 | Cayman Islands | — | 469 |
| AVIGEN INC \DE Delisted | — | United States of America | — | 469 |
| BIOVEST INTERNATIONAL INC Delisted | — | United States of America | — | 469 |
| MediciNova,Inc. | 4875 | Japan | — | 468 |
| MZT Holdings, Inc. Delisted | — | United States of America | — | 468 |
| CRISM Therapeutics Corporation | CRTX | Virgin Islands (British) | — | 464 |
| HBM Holdings Limited | 2142 | Cayman Islands | — | 464 |
| Synvista Therapeutics, Inc. Delisted | — | United States of America | — | 462 |
| Orchestra Therapeutics Inc Delisted | OCHTQ | United States of America | — | 461 |
| Cerevel Therapeutics Holdings Inc Delisted | CERE | United States of America | — | 459 |
| CORESTEMCHEMON Inc. | 166480 | South Korea | — | 459 |
| ACUSPHERE INC Delisted | — | United States of America | — | 454 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.